Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment

被引:0
|
作者
Daniel, WA
Syrek, M
Mach, A
Wojcikowski, J
Boksa, J
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Pharmacokinet & Drug Metab, PL-31343 Krakow, Poland
[2] Polish Acad Sci, Inst Pharmacol, Dept Drug Chem, PL-31343 Krakow, Poland
来源
POLISH JOURNAL OF PHARMACOLOGY | 1997年 / 49卷 / 06期
关键词
pharmacokinetics; plasma; brain; thioridazine; mesoridazine; sulforidazine; N-desmethylthioridazine; ring sulfoxide;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study was aimed at investigation of the pharmacokinetics of thioridazine and its metabolites after a single and repeated administrations. Male Wistar rats received thioridazine as a single dose (10 mg/kg ip) or they were treated chronically with the neuroleptic (10 mg/kg ip, twice a day for two weeks). Plasma and brain concentrations of thioridazine and its metabolites (N-desmethylthioridazine, mesoridazine, sulforidazine, and the ring sulfoxide) were determined using the HPLC method. The obtained data showed that sulfoxidation in position 2 of the thiomethyl substituent and in the thiazine ring are main metabolic pathways of thioridazine, and showed that, in contrast to humans, in the rat N-desmethylthioridazine is formed in appreciable amount. The biotransformation of thioridazine was rather fast yielding plasma peak concentrations of metabolites lower than that of the parent compound. The maximum concentrations of thioridazine and its metabolites in the brain appeared later than in plasma. The peak concentrations and AUC values of thioridazine and its metabolites were higher in the brain than in plasma and this corresponded well with their longer half-lives in the brain as compared to plasma. The drug was not taken up by the brain as efficiently as other phenothiazines, Chronic treatment with thioridazine produced significant increases (with the exception of thioridazine ring sulfoxide) in the plasma concentrations of the parent compound and its metabolites which was accompanied with the prolongation of their plasma half-lives. The observed plasma levels of thioridazine were within 'therapeutic range' while the concentrations of its metabolites were relatively lower as compared to those observed in psychiatric patients. The increased plasma concentrations of thioridazine and its metabolites observed in plasma after chronic treatment were not followed by parallel changes in the brain.
引用
收藏
页码:439 / 452
页数:14
相关论文
共 50 条
  • [41] ANALYSIS OF THIORIDAZINE AND SOME OF ITS METABOLITES IN BLOOD BY LIQUID CHRONOMATOGRAPHY - MUUSZE,RG
    CUYPER, HD
    TIJDSCHRIFT VOOR PSYCHIATRIE, 1976, 18 (09): : 638 - 638
  • [42] Circadian variations in the pharmacokinetics of capecitabine and its metabolites in rats
    Kobuchi, Shinji
    Yazaki, Yukiko
    Ito, Yukako
    Sakaeda, Toshiyuki
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 112 : 152 - 158
  • [43] Effect of decursin on the pharmacokinetics of theophylline and its metabolites in rats
    Chae, Jung-woo
    Baek, In-hwan
    Kwon, Kwang-il
    JOURNAL OF ETHNOPHARMACOLOGY, 2012, 144 (02) : 248 - 254
  • [44] Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats
    J. M. Huang
    W. Y. Weng
    X. B. Huang
    Y. H. Ji
    E. Chen
    European Journal of Drug Metabolism and Pharmacokinetics, 2005, 30 : 165 - 170
  • [45] The Pharmacokinetics and Tissue Distribution of Honokiol and its Metabolites in Rats
    Wang Jun-jun
    Miao Xiao-lei
    Chen Jing-ya
    Chen Yong
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 587 - 594
  • [46] Pharmacokinetics of scutellarin and its aglycone conjugated metabolites in rats
    Huang, JM
    Weng, WY
    Huang, XB
    Ji, YH
    Chen, E
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2005, 30 (03) : 165 - 170
  • [47] The Pharmacokinetics and Tissue Distribution of Honokiol and its Metabolites in Rats
    Wang Jun-jun
    Miao Xiao-lei
    Chen Jing-ya
    Chen Yong
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (05) : 587 - 594
  • [48] Pharmacokinetics and distribution of schisandrol A and its major metabolites in rats
    Liu, Xu
    Cong, Lixin
    Wang, Chunmei
    Li, He
    Zhang, Chengyi
    Guan, Xingang
    Liu, Peng
    Xie, Yu
    Chen, Jianguang
    Sun, Jinghui
    XENOBIOTICA, 2019, 49 (03) : 322 - 331
  • [49] Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats
    Feng, Xinchi
    Wang, Kun
    Cao, Shijie
    Ding, Liqin
    Qiu, Feng
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [50] Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects
    Kroesser, Sonja
    Marquet, Anne
    Gallemann, Dieter
    Wolna, Peter
    Fauchoux, Nicolas
    Hermann, Robert
    Johne, Andreas
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (09) : 550 - 559